Searchable abstracts of presentations at key conferences in endocrinology

ea0025s2.1 | Novel pathways and treatments in neuroendocrine tumours | SFEBES2011

Signaling pathways in neuroendocrine tumors

Kidd Mark , Modlin I

Neuroendocrine tumor cells express a diverse array of activating and inhibitory receptors. Each receptor transduces a signal via individual pathways which often interact or overlap. Common stimulatory receptor families include those for EGF/TGFα, FGF, IGF, PDGF, VEGF, and TGFβ. EGF receptor (Her 1) activation results in several signal transduction cascades including Ras/Raf, MAPK, AKT and JNK leading to DNA synthesis and cell proliferation. Activated MAPK signaling i...

ea0019p176 | Endocrine tumours and neoplasia | SFEBES2009

Adenosine A2 receptor signalling mediates chromogranin A secretion from neuroendocrine Tumours

Kalhan A , Vazquez M , Jasani B , Stott J , Neal J , Gharibi B , Kidd M , Modlin I , Pfragner R , Rees D , Ham J

Neuroendocrine tumors (NETs) of GI tract are a heterogeneous group of neoplasms that secrete peptides and amines. Small bowel NETs originate from enterochromaffin (EC) cells and secrete chromogranin A (CgA) and serotonin (5-HT). NETs are highly vascular, a reflection of increased tumour related angiogenesis. Adenosine, the major regulator of angiogenesis, is released by enhanced degradation of ATP, during cellular stress, damage and hypoxia.Aims: Aims of...